Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Megan L. Sell
Observed names:
M.L. Sell,
Megan Sell
Institution:
Medical University of South Carolina
Observed institutions:
Medical University of South Carolina,
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute,
The Ohio State University
ORCID:
0000-0002-4858-9091
Observed ORCID:
0000-0002-4858-9091
OpenAlex ID:
A5085667963
Safety and Immunogenicity of Live Viral Vaccines in a Multicenter Cohort of Pediatric Transplant Recipients
2023
·
Amy G. Feldman
, Brenda L. Beaty
, et al.
·
JAMA Network Open
·
55
PDF
First Interim Results of a Phase I/II Study of Lenalidomide in Combination with Anti-PD-1 Monoclonal Antibody MDV9300 (CT-011) in Patients with Relapsed/Refractory Multiple Myeloma
2015
·
Yvonne A. Efebera
, Ashley E Rosko
, et al.
·
Blood
·
17
Postvaccination Immunogenicity Among Pediatric Solid Organ Transplant Recipients
2025
·
Amy G. Feldman
, Brenda L. Beaty
, et al.
·
Archives of Pediatrics and Adolescent Medicine
·
12
Important considerations for drugs, nutritional, and herbal supplements in pediatric solid organ transplant recipients
2020
·
Nicole A. Pilch
, Megan L. Sell
, et al.
·
Pediatric Transplantation
·
7
Phase I Study of AR-42 in Relapsed Multiple Myeloma and Lymphoma.
2012
·
Craig C. Hofmeister
, Zhongfa Liu
, et al.
·
Blood
·
7
Phase I Trial of Lenalidomide + Vorinostat After Autologous Transplant in Multiple Myeloma.
2012
·
Craig C. Hofmeister
, Mindy A Bowers
, et al.
·
Blood
·
3
Improved Treatment Related Mortality in Patients with Primary Systemic Amyloidosis (AL Amyloidosis) undergoing Autologous Hematopoietic Stem Cell Transplant (aHSCT)
2019
·
Akshata Pandit
, Lai Wei
, et al.
·
Archives of Hematology and Blood Diseases
·
2
PDF
Post Autologous Transplant Vorinostat (SAHA) in High Risk Lymphoma: Phase 1 Study of Vorinostat Maintenance
2012
·
Craig C. Hofmeister
, Mindy A Bowers
, et al.
·
Blood
·
2
A Single Center Approach to Managing Hospitalized Patients with Quantitative Fibrinogen Deficiency That Cost-Saving and Maintains High-Quality, Evidence-Based Care
2024
·
Kimberley Youkhana
, Megan Sell
, et al.
·
Blood
·
1
PDF
An Anti-CD38 Directed Antibody for the Treatment for Appropriate Patients with Relapsed Refractory Multiple Myeloma
2020
·
Megan Sell
·
62nd ASH Annual Meeting and Exposition
Safety and Efficacy of Rabbit Anti-Thymocyte Globulin Induction in Pediatric Patients Undergoing Cardiac Transplantation
2018
·
M.L. Sell
, A.L. Haney
, et al.
·
The Journal of Heart and Lung Transplantation
Autologous Hematopoietic Stem Cell Transplant (aHSCT) is a Safe and Reasonable Treatment in Patients with Primary Systemic Amyloidosis (AL amyloidosis)
2013
·
Akshata Pandit
, Lai Wei
, et al.
·
Transplantation and Cellular Therapy
Immune Reconstitution and Quality of Life Analyses After Autologous Transplant for Multiple Myeloma
2012
·
Craig C. Hofmeister
, Mindy A Bowers
, et al.
·
Blood
Show more works
View as search
Works count:
13
Citation count:
106
H-index:
5
I10-index:
3
Year
Topic
Type